iSpecimen acquires two Foldlab AI products for $4.5 million
ISPC•iSpecimen completed its $4.5 million acquisition of two Foldlab AI products on November 2, 2026. The consideration includes $750,000 in cash, up to $1.25 million in milestone payments and $2.5 million in common stock.
1. Deal consideration
The acquired products identify disease-associated proteins and predict disease trends, expanding iSpecimen’s biospecimen marketplace into AI-powered disease intelligence. The purchase includes $750,000 in cash paid at closing, up to $1.25 million in two milestone payments of $625,000 each, and $2.5 million in common stock, totaling 2,907,977 shares.
